ERD

Periodic Reporting for period 3 - RESHAPE (Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Gen...

Project: RESHAPE

Updated at: 31-05-2024

Show more information

Project acronym RESHAPE

Final statement on IL-tgTreg

Project: RESHAPE

Updated at: 12-04-2024

Show more information

Project acronym RESHAPE

Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edi...

Project: RESHAPE

Updated at: 14-11-2023

Show more information

Project acronym RESHAPE

Review: Sustainable Clinical Development of CAR-T Cells - Switching From Viral Transduction Towards CRISPR-Cas Gene Edit...

Project: RESHAPE

Updated at: 14-11-2023

Show more information

Project acronym RESHAPE

Generation of Chimeric Antigen Receptors against Tetraspanin 7

Project: RESHAPE

Updated at: 14-11-2023

Show more information

Project acronym RESHAPE

Severe Multiple Sclerosis patients exhibit functionally altered CD8+ regulatory T cells.

Project: RESHAPE

Updated at: 14-11-2023

Show more information

Project acronym RESHAPE

Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg p...

Project: RESHAPE

Updated at: 14-11-2023

Show more information

Project acronym RESHAPE

Pharmacological interventions enhance virus-free generation of TRAC-replaced CAR T cells

Project: RESHAPE

Updated at: 14-11-2023

Show more information

Project acronym RESHAPE

Adoptive transfer of ex vivo expanded regulatory T cells improves immune cell engraftment and therapy-refractory chronic...

Project: RESHAPE

Updated at: 14-11-2023

Show more information

Project acronym RESHAPE

Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospective

Project: RESHAPE

Updated at: 14-11-2023

Show more information

Project acronym RESHAPE

Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis

Project: RESHAPE

Updated at: 31-07-2023

Show more information

Project acronym RESHAPE

Genetic engineering of human and mouse CD4+ and CD8+ Tregs using lentiviral vectors encoding chimeric antigen receptors

Project: RESHAPE

Updated at: 31-07-2023

Show more information

Project acronym RESHAPE

Cas9-directed immune tolerance in humans-a model to evaluate regulatory T cells in gene therapy?

Project: RESHAPE

Updated at: 31-07-2023

Show more information

Project acronym RESHAPE

Chimeric Antigen Receptors and Regulatory T Cells: The Potential for HLA-Specific Immunosuppression in Transplantation

Project: RESHAPE

Updated at: 31-07-2023

Show more information

Project acronym RESHAPE

Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use

Project: RESHAPE

Updated at: 31-07-2023

Show more information

Project acronym RESHAPE

Targeted De-Methylation of the FOXP3-TSDR Is Sufficient to Induce Physiological FOXP3 Expression but Not a Functional Tr...

Project: RESHAPE

Updated at: 31-07-2023

Show more information

Project acronym RESHAPE

Anti-CD20 Therapy Alters the Protein Signature in Experimental Murine AIH, but Not Exclusively towards Regeneration

Project: RESHAPE

Updated at: 31-07-2023

Show more information

Project acronym RESHAPE

Detection of SARS-CoV-2-specific memory B cells to delineate long-term COVID-19 immunity

Project: RESHAPE

Updated at: 31-07-2023

Show more information

Project acronym RESHAPE

In Vivo Analysis of Human Immune Responses in Immunodeficient Rats

Project: RESHAPE

Updated at: 31-07-2023

Show more information

Project acronym RESHAPE

Post-marketing safety and efficacy surveillance of cell and gene therapies in the EU: A critical review

Project: RESHAPE

Updated at: 31-07-2023

Show more information

Project acronym RESHAPE

Humanization of Immunodeficient Animals for the Modeling of Transplantation, Graft Versus Host Disease and Regenerative ...

Project: RESHAPE

Updated at: 31-07-2023

Show more information

Project acronym RESHAPE

Super-Treg: Toward a New Era of Adoptive Treg Therapy Enabled by Genetic Modifications

Project: RESHAPE

Updated at: 31-07-2023

Show more information

Project acronym RESHAPE

New frontiers: cellular immunotherapy beyond cancer

Project: RESHAPE

Updated at: 31-07-2023

Show more information

Project acronym RESHAPE

TCAIM controls effector T cell generation by preventing Mitochondria-Endoplasmic Reticulum Contact Site-initiated Choles...

Project: RESHAPE

Updated at: 31-07-2023

Show more information

Project acronym RESHAPE

Cyclosporine A but Not Corticosteroids Support Efficacy of Ex Vivo Expanded, Adoptively Transferred Human Tregs in GvHD

Project: RESHAPE

Updated at: 31-07-2023

Show more information

Project acronym RESHAPE

Future prospects for CD8 + regulatory T cells in immune tolerance

Project: RESHAPE

Updated at: 31-07-2023

Show more information

Project acronym RESHAPE

Toward an Optimized Process for Clinical Manufacturing of CAR-Treg Cell Therapy

Project: RESHAPE

Updated at: 31-07-2023

Show more information

Project acronym RESHAPE

Fast, efficient and virus-free generation of TRAC-replaced CAR T cells

Project: RESHAPE

Updated at: 31-07-2023

Show more information

Project acronym RESHAPE

Recent advances in our understanding of the allograft response

Project: RESHAPE

Updated at: 31-07-2023

Show more information

Project acronym RESHAPE

Position paper Crispr/Cas in Tcells

Project: RESHAPE

Updated at: 31-07-2023

Show more information

Project acronym RESHAPE

Resources

Selected filters:

Periodic Reporting for period 3 - RESHAPE (Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Gen...

Final statement on IL-tgTreg

Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edi...

Review: Sustainable Clinical Development of CAR-T Cells - Switching From Viral Transduction Towards CRISPR-Cas Gene Edit...

Generation of Chimeric Antigen Receptors against Tetraspanin 7

Severe Multiple Sclerosis patients exhibit functionally altered CD8+ regulatory T cells.

Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg p...

Pharmacological interventions enhance virus-free generation of TRAC-replaced CAR T cells

Adoptive transfer of ex vivo expanded regulatory T cells improves immune cell engraftment and therapy-refractory chronic...

Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospective

Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitis

Genetic engineering of human and mouse CD4+ and CD8+ Tregs using lentiviral vectors encoding chimeric antigen receptors

Cas9-directed immune tolerance in humans-a model to evaluate regulatory T cells in gene therapy?

Chimeric Antigen Receptors and Regulatory T Cells: The Potential for HLA-Specific Immunosuppression in Transplantation

Identification, selection, and expansion of non-gene modified alloantigen-reactive Tregs for clinical therapeutic use

Targeted De-Methylation of the FOXP3-TSDR Is Sufficient to Induce Physiological FOXP3 Expression but Not a Functional Tr...

Anti-CD20 Therapy Alters the Protein Signature in Experimental Murine AIH, but Not Exclusively towards Regeneration

Detection of SARS-CoV-2-specific memory B cells to delineate long-term COVID-19 immunity

In Vivo Analysis of Human Immune Responses in Immunodeficient Rats

Post-marketing safety and efficacy surveillance of cell and gene therapies in the EU: A critical review

Humanization of Immunodeficient Animals for the Modeling of Transplantation, Graft Versus Host Disease and Regenerative ...

Super-Treg: Toward a New Era of Adoptive Treg Therapy Enabled by Genetic Modifications

New frontiers: cellular immunotherapy beyond cancer

TCAIM controls effector T cell generation by preventing Mitochondria-Endoplasmic Reticulum Contact Site-initiated Choles...

Cyclosporine A but Not Corticosteroids Support Efficacy of Ex Vivo Expanded, Adoptively Transferred Human Tregs in GvHD

Future prospects for CD8 + regulatory T cells in immune tolerance

Toward an Optimized Process for Clinical Manufacturing of CAR-Treg Cell Therapy

Fast, efficient and virus-free generation of TRAC-replaced CAR T cells

Recent advances in our understanding of the allograft response

Position paper Crispr/Cas in Tcells